Stock LEL ELI LILLY AND COMPANY
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Eli Lilly and Company London S.E.

Equities

LEL

US5324571083

Market Closed - London S.E.
Other stock markets
 08:07:36 10/12/2021 pm IST 		5-day change 1st Jan Change
225.3 CHF -1.50% Intraday chart for Eli Lilly and Company -58.28% -58.28%
26/06 Augustine Therapeutics N.V. announced that it expects to receive funding from a group of investors CI
25/06 Top Midday Stories: Microsoft Hit with EU Antitrust Charges; Judge Blocks Swipe-Fee Settlement Between Visa, Mastercard and Retailers; Novo Nordisk Secures Chinese Approval for Weight-Loss Drug; Tesla, Ford Issue Recalls MT

Chart calendar Eli Lilly and Company

22040632af4a83.TVnb0qwmG2F65LCXSzanHG0YzISGCMGRnL2fQXOlImE.Bz2E48ZFTSM5iePUJHjxLVgo_MP_Ypvz0Prxdwv1ahgfDOrl3WtJFhKK0w~1c23be0020375d7e93569367762ff10a

Upcoming events on Eli Lilly and Company

08/08/2024 03:55 pm Q2 2024 Earnings Release
08/08/2024 07:30 pm Q2 2024 Earnings Call
30/10/2024 03:55 pm Q3 2024 Earnings Release
30/10/2024 07:30 pm Q3 2024 Earnings Call
30/01/2025 Q4 2024 Earnings Release (Projected)
24/04/2025 Q1 2025 Earnings Release (Projected)
05/08/2025 Q2 2025 Earnings Release (Projected)
04/11/2025 Q3 2025 Earnings Release (Projected)

Past events on Eli Lilly and Company

22/06/2024 01:15 am American Diabetes Association Scientific Symposium
11/06/2024 01:30 am Goldman Sachs Global Healthcare Conference - Fireside Chat
04/06/2024 03:42 am American Society of Clinical Oncology Meeting - Abstract Number: LBA507
04/06/2024 12:00 am American Society of Clinical Oncology Meeting - Abstract Number: 8547
03/06/2024 07:30 pm American Society of Clinical Oncology Meeting - Abstract Number: 5589
03/06/2024 07:30 pm American Society of Clinical Oncology Meeting - Abstract Number: 11111
03/06/2024 07:30 pm American Society of Clinical Oncology Meeting - Abstract Number: 11068
03/06/2024 06:00 am American Society of Clinical Oncology Meeting
03/06/2024 03:36 am American Society of Clinical Oncology Meeting - Abstract Number: 10022
02/06/2024 07:30 pm American Society of Clinical Oncology Meeting - Abstract Number: 1027
02/06/2024 03:30 am American Society of Clinical Oncology Meeting - Abstract Number: 3007
02/06/2024 01:42 am American Society of Clinical Oncology Meeting - Abstract Number: 5001
02/06/2024 01:30 am American Society of Clinical Oncology Meeting - Abstract Number: LBA1001
02/06/2024 12:09 am American Society of Clinical Oncology Meeting - Abstract Number: 8510
01/06/2024 07:30 pm American Society of Clinical Oncology Meeting - Abstract Number: 3150
15/05/2024 Détachement de
06/05/2024 06:00 pm Annual General Meeting
30/04/2024 07:30 pm Q1 2024 Earnings Call
30/04/2024 04:15 pm Q1 2024 Earnings Release
09/04/2024 02:00 am American Association for Cancer Research Meeting - Abstract Number: 3230

Past dividends on Eli Lilly and Company

15/05/2024 Quarterly 1.3 USD
14/02/2024 Quarterly 1.3 USD
14/11/2023 Quarterly 1.13 USD
14/08/2023 Quarterly 1.13 USD
12/05/2023 Quarterly 1.13 USD
14/02/2023 Quarterly 1.13 USD
14/11/2022 Quarterly 0.98 USD
12/08/2022 Quarterly 0.98 USD
13/05/2022 Quarterly 0.98 USD
14/02/2022 Quarterly 0.98 USD

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		22 320
22 142
0.8%		24 540
24 394
0.6%		28 318
28 205
0.4%		28 541
28 641
-0.35%		34 124
33 585
1.6%
42 982

EBITDA
Million USD		Released
Forecast
Spread 		7 551
7 508
0.57%		8 589
8 676
-1.01%		10 005
9 767
2.43%		9 473
9 494
-0.23%		8 584
8 418
1.98%
16 272

EBIT
Million USD		Released
Forecast
Spread 		6 079
6 106
-0.44%		7 265
7 503
-3.17%		8 457
8 599
-1.65%		7 950
8 164
-2.62%		7 057
6 928
1.86%
14 707

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		5 266
8 975
-41.33%		7 230
7 041
2.68%		6 156
7 148
-13.88%		6 806
7 084
-3.93%		6 555
6 311
3.86%
13 737

Net income
Million USD		Released
Forecast
Spread 		8 318
8 090
2.83%		6 194
5 805
6.69%		5 582
6 019
-7.27%		6 245
6 102
2.35%		5 240
5 307
-1.26%
11 932

EPS
USD		Released
Forecast
Spread 		8,89
8,65
2.83%		6,79
6,36
6.69%		6,12
6,43
-4.75%		6,90
6,60
4.57%		5,80
6,04
-3.92%
13,4

Announcement Date30/01/2029/01/2103/02/2202/02/2306/02/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD		Released
Forecast
Spread 		7 810
7 319
6.7%		6 488
6 854
-5.33%		6 942
6 901
0.58%		7 302
7 376
-1%		6 960
6 867
1.36%		8 312
7 590
9.51%		9 499
8 965
5.96%		9 353
8 971
4.27%		8 768
8 930
-1.81%
10 000


11 327


12 781


10 920


12 135

EBITDA
Million USD		Released
Forecast
Spread 		3 046
2 717
12.12%		1 679
2 387
-29.67%		2 373
2 385
-0.5%		2 375
2 268
4.72%		1 982
2 148
-7.73%		2 618
2 416
8.39%		986
3 460
-71.49%		2 855
3 517
-18.81%		3 049
2 827
7.84%
3 750


4 844


5 994







EBIT
Million USD		Released
Forecast
Spread 		2 610
2 336
11.74%		1 330
1 790
-25.7%		2 010
2 007
0.13%		2 000
1 953
2.41%		1 620
1 840
-11.95%		2 252
2 078
8.37%		575
921
-37.56%		2 468
2 448
0.79%		2 648
2 674
-0.96%
3 078


3 976


4 812







Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread














2 089
2 107
-0.86%		427
-399
207.07%		2 509
1 248
101.03%		2 536
2 455
3.3%
3 000


3 878


4 497







Net income
Million USD		Released
Forecast
Spread 		1 903
1 711
11.22%		953
1 133
-15.93%		1 452
1 453
-0.09%		1 938
1 681
15.27%		1 345
1 544
-12.9%		1 763
1 660
6.22%		-57,4
-813
92.94%		2 190
1 811
20.89%		2 243
2 058
8.99%
2 477


3 249


4 025







EPS
USD		Released
Forecast
Spread


1,05
1,85
-43.24%		1,61
1,90
-15.26%		2,14
1,78
20.22%		1,49
2,04
-26.96%		1,95
1,81
7.73%		-0,06
-0,66
90.91%		2,42
2,26
7%		2,48
2,44
1.64%
2,77


3,60


4,46







Announcement Date28/04/2204/08/2201/11/2202/02/2327/04/2308/08/2302/11/2306/02/2430/04/24-----

Upcoming sector events for Eli Lilly and Company

04/07/2024 HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2024 Earnings Release (Projected)
11/07/2024 HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2025 Earnings Release
16/07/2024 CAMURUS AB: Q2 2024 Earnings Release
17/07/2024 GLAND PHARMA LIMITED: Q1 2025 Earnings Release (Projected)
17/07/2024 04:15 pm JOHNSON & JOHNSON: Q2 2024 Earnings Release
18/07/2024 JUBILANT PHARMOVA LIMITED: Q1 2025 Earnings Release (Projected)
18/07/2024 10:30 am NOVARTIS AG: Q2 2024 Earnings Release
22/07/2024 GLAXOSMITHKLINE PHARMACEUTICALS LIMITED: Q1 2025 Earnings Release (Projected)
22/07/2024 ALMIRALL, S.A.: Q2 2024 Earnings Release
23/07/2024 TORRENT PHARMACEUTICALS LIMITED: Q1 2025 Earnings Release (Projected)
More events

Past sector events for Eli Lilly and Company

21/06/2024 08:58 pm DEVA HOLDING: Q1 2024 Earnings Release
14/06/2024 02:51 am EIS ECZACIBASI ILAÇ, SINAI VE FINANSAL YATIRIMLAR SANAYI VE TICARET: Q1 2024 Earnings Release
11/06/2024 11:00 am BORA PHARMACEUTICALS CO., LTD.: June 2024 Sales and Revenue Release
07/06/2024 04:03 pm SCINOPHARM TAIWAN, LTD.: May 2024 Sales and Revenue Release
07/06/2024 02:47 pm LOTUS PHARMACEUTICAL CO., LTD.: May 2024 Sales and Revenue Release
30/05/2024 05:38 pm SUVEN PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release
30/05/2024 04:30 pm ROIVANT SCIENCES LTD.: Q4 2023 Earnings Release
30/05/2024 11:54 am MARKSANS PHARMA LIMITED: Q4 2024 Earnings Release
29/05/2024 05:30 pm FDC LIMITED: Q4 2024 Earnings Release
29/05/2024 02:56 pm JUBILANT PHARMOVA LIMITED: Q4 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. LLY Stock
  4. LEL Stock
  5. Calendar Eli Lilly and Company